16 July 2018 - - Waltham, Massachusetts-based life sciences company Thermo Fisher Scientific's advanced diagnostic allergic sensitization tests will be offered by Heal, a physician house call service, the company said.
If, during a home visit, a Heal-network physician suspects an allergy and wishes to help confirm or rule out that suspicion with diagnostic tests, he or she can draw a blood sample to be processed in a qualified lab using Thermo Fisher's ImmunoCAP test.
ImmunoCAP, an IgE blood test documented as accurate in more than 4,000 peer-reviewed publications, can identify allergic sensitisation to common environmental allergens as well as common food allergies.
The tests can be ordered for patients of any age regardless of skin condition, current medication, symptom, disease activity or pregnancy status.
Unlike a skin prick test, for which the clinician would need to interpret a response onsite, the results from the Thermo Fisher in vitro diagnostics test can be reviewed later during follow-up with the patient, which may not require an actual face-to-face encounter.
Thermo Fisher Scientific has revenues of USD 18bn and more than 55,000 employees globally.
The company helps its customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity.